When prescribing oral isotretinoin to adolescents, we query them regarding their sexual
activity and use of contraception. Often these questions are posed in front of their
parent/guardian(s) while completing the iPLEDGE consent form. Patient and parent discomfort
is often apparent when we ask these questions. Answers to these questions have become
even more pertinent as, in many states, access to an abortion for an unwanted pregnancy
while on isotretinoin might be challenging and require travel to another state. Are
there ethical issues we need to consider regarding this scenario?
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Clinics in DermatologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
Publication stage
In Press Accepted ManuscriptFootnotes
Edited by Stephen P. Stone, MD
Funding: None
COI: None
Identification
Copyright
© 2022 Published by Elsevier Inc.
